LEUKEMIA, MYELOID

This early-stage study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and tolerable for patients. It focuses on adults with acute myeloid leukemia that has returned or not responded to prior therapy and has specific geneti…

This study is testing a new drug called asciminib for adults newly diagnosed with a type of blood cancer called chronic myeloid leukemia. The goal is to see if asciminib, taken alone or later combined with a low dose of another standard drug, can effectively control the disease. …

This is an early-stage study to test the safety of a new cell therapy for adults with acute myeloid leukemia (AML). Researchers are combining specially trained immune cells, called CIML NK cells, with a standard drug (venetoclax) to try to better control the cancer. The study wil…

This early-stage study is testing a new therapy that uses specially trained immune cells from a donor to try to prevent blood cancers from coming back after a stem cell transplant. The goal is to see if these 'memory-like' natural killer (NK) cells, given with a supporting drug, …

This is the first time researchers are giving a new oral drug called BH-30236 to people. The study aims to find a safe dose and see if the drug can help control two aggressive blood cancers—acute myeloid leukemia or myelodysplastic syndrome—that have come back or haven't responde…